Skip to main content

A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease (TargetTau-1)

Open
  • Protocol code: CN008-0003
  • EudraCT code: No aplica
  • Research group: Neurovascular Diseases
  • Service: Neurology
  • Principal investigator:  Delgado Martínez, Maria Pilar
  • Pathology: Malalties del sistema nerviós
  • Phase: Fase II